Jade Biosciences, Inc. Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance
Jade Biosciences, Inc. (JBIO) had Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance of 230.00 thousand shares as of 2022-06-30, per its 10-Q filed 2022-08-15.
Discontinued › Notes › Compensation Related Costs
us-gaap:DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance · last filed 2022-08-15
- 2022-06-30: Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance 230.00K shares.
- 2022-03-31: Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance 230.00K shares.
- 2021-12-31: Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance 230.00K shares.
- 2021-09-30: Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance 230.00K shares.
| Period end | Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance |
|---|---|
| 2022-06-30 | 230.00K shares 10-Q · filed 2022-08-15 |
| 2022-03-31 | 230.00K shares 10-Q · filed 2022-05-16 |
| 2021-12-31 | 230.00K shares 10-K · filed 2022-03-30 |
| 2021-09-30 | 230.00K shares 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |